exercise programs for clients taking glp-1 medications The #GLP1 receptor agonists reduce appetite and greatly facilitate weight loss. Robert Kushner, MD, of Northwestern University Feinberg School of Medicine joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss appropriate If you're taking GLP-1's and

One person loses mostly fat while preserving most of their muscle

When your levels are balanced, your body can handle stress, toxins, and daily challenges more effectively

95 observed a biphasic medullary blood flow following i.v

Tirzepatide carries a boxed warning regarding thyroid C-cell tumors observed in rodent studies

The ACC document, which was endorsed by the American Diabetes Association (ADA), outlined a variety of considerations for use of these agents in patients with ASCVD, including considerations that may warrant selection of either a GLP-1 RA or an SGLT-2 inhibitor for cardiovascular risk reduction ( Table 1 )